🔎 Trials Near Me

Home › Cancer (all types) › NCT03269578

Sample Collection and Tracking for the Developmental Therapeutics Clinic

RecruitingObservational study

Longitudinal Sample Collection and Tracking for the Developmental Therapeutics Clinic, National Cancer Institute

Who can join

Ages 18 to 120 · All sexes

Full eligibility criteria
* INCLUSION CRITERIA:
* Patients who are being evaluated and/or treated for cancer or benign tuumors in the Developmental Therapeutics Clinic at the NIH Clinical Center
* Ability to understand and willingness to sign a written informed consent document indicating their willingness to have data from their tissue or biologic fluid research specimens and limited medial information used for research as outlined in this protocol and to allow protocol staff access to the CRIS database and their Medical Records Number (MRN).
* Age greater than or equal to 18 years

ECLUSION CRITERIA:

None

About the study

Background:

People who join a study in the Developmental Therapeutics Clinic (DTC) have tests. These include blood draws and biopsies. Researchers collect data from these samples. Some people take part in more than one study at the DTC. At this time, data are connected only with one single study. Researchers want to access people s medical records. This will allow them to link the research data from all their studies they have or will take part in. Researchers also want to collect medical data about their diagnosis and treatment history. This will allow them to see how their cancer reacted to different drugs over time.

Objective:

To enter people into a master protocol to connect research sample and treatment data across DTC studies.

Eligibility:

People ages 18 and older who are being evaluated or treated for cancer in the DTC

Design:

Participants will allow researchers to look at all the data from their research samples. This includes those from their current, past, and any future NIH studies.

Participants will allow researchers to access some of their medical data. This includes age, diagnosis, treatment history, and response to treatment.

Participants will provide no new samples.

...

Sponsor: National Cancer Institute (NCI) · Participants: 3,000 · Started: Aug 28, 2017

Contact the study team

Official record on ClinicalTrials.gov — NCT03269578

Locations in the U.S.

MarylandNational Institutes of Health Clinical Center, Bethesda

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.